Skip to content
TrialScanner

NCT04406623

Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer

Phase 1CompletedSTTKLead

Registry record

Lead sponsor
Shattuck Labs, Inc.
Conditions
Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma
Primary completion
Feb 2, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04406623 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04406623: Phase 1 Study of SL-172154... | TrialScanner